{
    "2021-06-07": [
        [
            {
                "time": "2023-10-10",
                "original_text": "Novartis (NVS) Posts Positive Data on Kidney Disease Candidate. Novartis's Iptacopan Aces Mid-Stage Kidney Disease Trial",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Iptacopan",
                        "Positive Data",
                        "Kidney Disease",
                        "Candidate",
                        "Mid-Stage",
                        "Trial"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}